vs
Allot Ltd.（ALLT）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Allot Ltd.的1.5倍（$35.5M vs $24.1M），Allot Ltd.净利率更高（-7.0% vs -304.2%，领先297.2%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 8.5%），Allot Ltd.自由现金流更多（$4.0M vs $-47.3M）
Allot Ltd.是一家以色列高科技企业，前身为Allot Communications，核心业务为电信软件开发，公司总部设于以色列霍德哈沙伦，在通信技术软件领域拥有深厚的技术积累。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
ALLT vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.5倍
$24.1M
营收增速更快
RXRX
高出673.2%
8.5%
净利率更高
ALLT
高出297.2%
-304.2%
自由现金流更多
ALLT
多$51.3M
$-47.3M
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $24.1M | $35.5M |
| 净利润 | $-1.7M | $-108.1M |
| 毛利率 | 72.1% | 59.8% |
| 营业利润率 | -1.7% | -304.8% |
| 净利率 | -7.0% | -304.2% |
| 营收同比 | 8.5% | 681.7% |
| 净利润同比 | 49.6% | 39.6% |
| 每股收益（稀释后） | $-0.04 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALLTRXRX
| Q4 25 | — | $35.5M | ||
| Q3 25 | — | $5.2M | ||
| Q2 25 | $24.1M | $19.2M | ||
| Q1 25 | $23.1M | $14.7M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | — | $26.1M | ||
| Q2 24 | $22.2M | $14.4M | ||
| Q1 24 | — | $13.8M |
净利润ALLTRXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | — | $-162.3M | ||
| Q2 25 | $-1.7M | $-171.9M | ||
| Q1 25 | $-332.0K | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | — | $-95.8M | ||
| Q2 24 | $-3.4M | $-97.5M | ||
| Q1 24 | — | $-91.4M |
毛利率ALLTRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | 72.1% | -4.9% | ||
| Q1 25 | 69.3% | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | 68.5% | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率ALLTRXRX
| Q4 25 | — | -304.8% | ||
| Q3 25 | — | -3327.6% | ||
| Q2 25 | -1.7% | -916.8% | ||
| Q1 25 | -3.1% | -1297.9% | ||
| Q4 24 | — | -4042.4% | ||
| Q3 24 | — | -377.1% | ||
| Q2 24 | -15.2% | -697.4% | ||
| Q1 24 | — | -698.4% |
净利率ALLTRXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | — | -3135.3% | ||
| Q2 25 | -7.0% | -894.2% | ||
| Q1 25 | -1.4% | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | — | -367.5% | ||
| Q2 24 | -15.1% | -676.6% | ||
| Q1 24 | — | -662.4% |
每股收益（稀释后）ALLTRXRX
| Q4 25 | — | $-0.17 | ||
| Q3 25 | — | $-0.36 | ||
| Q2 25 | $-0.04 | $-0.41 | ||
| Q1 25 | $-0.01 | $-0.50 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | $-0.09 | $-0.40 | ||
| Q1 24 | — | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $60.1M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $99.7M | $1.1B |
| 总资产 | $154.1M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资ALLTRXRX
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | $60.1M | $525.1M | ||
| Q1 25 | $10.1M | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | $15.9M | $474.3M | ||
| Q1 24 | — | $296.3M |
总债务ALLTRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益ALLTRXRX
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | $99.7M | $919.1M | ||
| Q1 25 | $50.0M | $933.9M | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | $524.6M | ||
| Q2 24 | $46.7M | $584.4M | ||
| Q1 24 | — | $401.2M |
总资产ALLTRXRX
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | $154.1M | $1.3B | ||
| Q1 25 | $140.3M | $1.3B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $726.5M | ||
| Q2 24 | $132.5M | $775.9M | ||
| Q1 24 | — | $557.8M |
负债/权益比ALLTRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.4M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $4.0M | $-47.3M |
| 自由现金流率自由现金流/营收 | 16.5% | -133.1% |
| 资本支出强度资本支出/营收 | 1.7% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-6.0M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流ALLTRXRX
| Q4 25 | — | $-46.1M | ||
| Q3 25 | — | $-117.4M | ||
| Q2 25 | $4.4M | $-76.4M | ||
| Q1 25 | $1.7M | $-132.0M | ||
| Q4 24 | — | $-115.4M | ||
| Q3 24 | — | $-59.2M | ||
| Q2 24 | $1.2M | $-82.2M | ||
| Q1 24 | — | $-102.3M |
自由现金流ALLTRXRX
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | $4.0M | $-79.6M | ||
| Q1 25 | $1.4M | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | $217.0K | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率ALLTRXRX
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | 16.5% | -413.9% | ||
| Q1 25 | 6.1% | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | 1.0% | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度ALLTRXRX
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | 1.7% | 16.4% | ||
| Q1 25 | 1.2% | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | 4.3% | 8.2% | ||
| Q1 24 | — | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
